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Abstract 
Background: Muscular strengthening activity (MSA) has been shown to be inversely 
associated with insulin resistance (IR). The associations between quartiles of the 
homeostatic model assessment of insulin resistance (HOMA-IR) and self-reported MSA 
in a nationally representative sample of euglycemic U.S. adults were examined.   
Methods: Sample included adult participants (≥20 years of age [n=2,543]) from the 
1999-2004 National Health and Nutrition Examination Survey (NHANES). HOMA-IR 
was categorized into quartiles based on every 25th percentile. No MSA was the dependent 
variable.  
Results: Following adjustment for covariates, those with HOMA-IR values in third 
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of 
reporting no MSA. Following further adjustment for non-MSA specific leisure time 
physical activity, results remained significant (p<0.05 third, p<0.001 fourth). A 
significant positive trend was seen across quartiles of HOMA-IR (p=0.01) for odds of 
reporting no MSA.  
Conclusions: Having a higher HOMA-IR value is associated with greater odds of 
reporting no MSA in euglycemic U.S. adults.  
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Background 
 Insulin resistance (IR) is characterized by the inability of the body to properly 
utilize endogenous insulin in order to maintain glucose homeostasis. Insulin resistance 
has been shown to be highly associated with type 2 diabetes(1,2). Moreover, studies have 
also shown that IR is highly prevalent in subjects who are apparently healthy(3,4), 
approximately 1/3 of euglycemic adults. Bonora et al.(1) investigated the association 
between risk factors for type 2 diabetes and incidence of type 2 diabetes in white subjects 
without diabetes. Results revealed that subjects in the highest quartile of IR as well as 
subjects with lowered β-cell secretion rates had higher rates of incidence for type 2 
diabetes (p<0.001). Currently diabetes is estimated to affect approximately 8.3% of the 
population, both diagnosed and undiagnosed(5). According to a study conducted by 
Boyle et al.(6), diabetes prevalence is projected to reach between 21-33% by the year 
2050, depending upon incidence and mortality rates. The economic burden of diabetes in 
2012 was approximately $245 billion(7), a significant increase compared to the $174 
billion in 2007(8).         
 Many studies have shown a significant association between higher levels of IR 
and cardiovascular disease (CVD)(1,9,10); all-cause mortality(11) as well as several 
cardio metabolic risk factors such as obesity(12-14), inflammation(15,16), 
hypertension(18), dyslipidemia(13,17,19) and hyperglycemia(13,17) in subjects without 
diabetes. Hanley et al.(9) investigated the associations between higher levels of IR 
(categorized into quintiles) and CVD risk in Mexican Americans and Non-Hispanic 
Whites without diabetes. Results revealed a significant trend (p<0.0001) in risk for CVD 
across quintiles of IR. Furthermore, a significantly increased relative risk for CVD was 
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seen in those in the highest quintile of IR compared to the lowest (2.52, 95% CI 1.46–
4.36). Results also revealed a significant positive trend across quintiles for IR for several 
cardio metabolic risk factors including blood pressure, high-density lipoprotein 
cholesterol (negative trend [HDL-C]), low-density lipoprotein cholesterol (LDL-C), 
adiposity measurements, fasting insulin and glucose and triglycerides.    
Traditional Approach-Muscular Strengthening Activity and Insulin Resistance 
 In order to properly treat or prevent the progression of IR, physical activity (PA), 
specifically muscular strengthening activity (MSA), has been investigated as a potential 
modality. Traditionally, MSA (or characteristics of MSA such as lean body mass or 
strength) has been investigated as the independent variable and IR as the dependent 
variable(20-28). Miller et al.(24) reported a significant reduction (37.5%, p<0.05) in basal 
insulin levels in response to an oral glucose tolerance test (OGTT)  in eight young 
healthy male subjects following a 10-week progressive MSA protocol, illustrating 
decreases in peripheral IR. Furthermore, Cheng et al.(21) investigated the associations 
between volumes of MSA and IR, measured via the quantitative insulin sensitivity check 
index (QUICKI), in subjects without diabetes utilizing data from the 1999-2004 National 
Health and Nutrition Examination Survey (NHANES). Results revealed a significant 
difference in QUCIKI levels for subjects reporting ≥1 day/week of MSA (p<0.05). 
Following adjustment for covariates, results remained significant in females but not 
males. Significance was only seen in volumes of MSA ≥3 days/week (p<0.05) in males. 
These data suggest that MSA is inversely associated with IR in apparently healthy 
subjects.  
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Non-traditional-Clinical Approach       
 A novel approach to surveillance data utilizes a model with the adverse metabolic 
condition as the independent variable and the health behavior as the dependent variable. 
This method provides insight into PA and MSA patterns among groups who are at greater 
metabolic risk. Few studies have used this model(29-33). Zhao et al.(32) reported that 
subjects with diabetes reported lower levels of total, moderate and vigorous PA compared 
to those without diabetes. Furthermore, subjects with diabetes had lower odds of 
reporting meeting the 2008 DHHS and 2007 American Diabetes Association PA 
recommendations compared to those without. Another cross-sectional analysis conducted 
by Zhao et al.(33) found similar associations between diabetes status and reported PA 
patterns among adults ≥65 years of age. Churilla et al.(29) reported the prevalence of 
meeting the 2008 DHHS PA recommendations to be 59.1% among participants reporting 
high-cholesterol (HC) and 68.3% among participants not reporting HC (p<0.05). Another 
study by Churilla et al.(30) reported significantly lowered odds (OR 0.85, 95% CI 0.82-
0.88) for meeting the DHHS PA recommendations in subjects with hypertension 
compared to those without hypertension. These studies, utilizing what could be viewed as 
a clinical approach to surveillance research all illustrate that at a population level, those 
with chronic conditions may be engaging in significantly lower volumes of PA, thus not 
receiving the proven health benefits of leading an active lifestyle. This approach to 
analyzing surveillance data may assist clinicians (e.g., physicians) in identifying those 
who need lifestyle counseling and PA recommendations.  
Physician Recommended Physical Activity      
 Barnes et al.(34) reported that the prevalence of doctors recommending exercise 
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or physical activity to adult patients is approximately 32.4% and is significantly higher in 
subjects with diabetes, CVD, or hypertension compared to those without. Despite these 
recommendations, Zhao et al.(32) showed that subjects with diabetes report being less 
active than those without diabetes. Interestingly, there have been no studies investigating 
specifically the prevalence of doctor recommended PA among subjects with IR, a highly 
prevalent, deleterious metabolic condition among euglycemic adults.   
Prevalence of Muscular Strengthening Activity      
 Currently, approximately 30% of the U.S. adult population meets the 2008 DHHS 
MSA recommendations of ≥2 days/week(35-38). From these prevalence estimates it can 
be deduced that 70% of U.S. adults are not participating in adequate amounts of MSA, 
which has been shown to reduce the risk of diabetes(39) and CVD(40) as well as reduce 
levels of IR. However, no studies have investigated the MSA among euglycemic subjects 
with IR.           
Purpose and Research Questions 
There is a paucity of literature investigating the relationship between IR and MSA 
in euglycemic adults. The proposed study will investigate the potential associations 
between quartiles of IR (via HOMA-IR) and self-reported MSA in euglycemic U.S. 
adults. The specific research questions addressed by this study are as follows:    
1. Is there a significant association between quartiles of HOMA-IR and self-
reported MSA in euglycemic U.S. adults? 
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2. Is there is a significant association between quartiles of HOMA-IR and self-
reported MSA in euglycemic U.S. adults adjusting for non-MSa specific leisure 
time physical activity (LTPA)? 
 To the best of our knowledge, this is the first study to investigate these 
associations utilizing HOMA-IR as the primary independent variable and MSA as the 
dependent variable. This is a novel approach to the study design characterized by using 
IR as an explanatory variable rather than the outcome variable. Ultimately, this study will 
add to the existing literature that investigates the relationship between IR and MSA as 
well as the literature utilizing metabolic health as the independent variable and health 
behavior as the dependent variable. 
Project Description 
 In this study the sample will be limited to adults ≥ 20 years of age that 
participated in the 1999-2004 NHANES. Non-fasted participants, participants with pre-
diabetes or diabetes, participants with missing data on any covariates, and pregnant 
women will be excluded from this study. There are several limitations inherent to the 
cross-sectional design: 
1. Inability to establish causality.  
2. Potential for recall bias due to the use of questionnaires to assess certain 
variables.  
3. The self-reported variables are subject to the social-desirability effect.  
4. Residual confounding.  
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Insulin Resistance: Definition, History, and Prevalence  
 Insulin resistance (IR) is characterized by the inability of the body’s tissues to 
proper utilize and respond to endogenous insulin(1). Insulin resistance manifests itself in 
the body though multiple mechanisms and at different sites. Two examples are: hepatic 
IR manifesting itself as impaired fasting glucose (IFG); and peripheral IR manifesting 
itself as impaired glucose tolerance (IGT)(2). Both of these states of glucose imbalance 
lead to metabolic issues attributable to hyperinsulinemia; which is considered a state of 
IR(1).            
 The idea of insulin insensitivity or “resistance” was first demonstrated in 1936 by 
Himsworth(3). It was in this study that the differentiation of insulin-sensitive diabetes 
(type 1) and insulin insensitive diabetes (type 2) was determined through specific tests 
investigating insulin response to carbohydrates. Furthermore, this study proposed several 
possibilities that could contribute to the insulin resistive state: 1) the liver may be pouring 
so much sugar into the blood that the effect of the injected insulin is overwhelmed; 2) the 
liver may be incapable of storing the ingested sugar; or 3) the characteristic action of 
insulin in promoting storage of blood-sugar in the peripheral tissues may be unable to 
manifest itself(3). In 1960, Yalow and Berson(4) suggested that insulin sensitivity, and 
not deficiency in insulin secretion, could play an important role in the hyperglycemia of 
diabetes.           
 Current prevalence estimates of IR vary depending on definition, site and 
measurement of IR(2). In the 1988 Banting lecture, Reaven(5) stated that IR is present in 
the majority of patients with IGT or type 2 diabetes and in approximately 25% of non-
obese individuals with normal oral glucose tolerance.  In a cross-sectional analysis 
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conducted by Ioannou et al.(6) prevalence of IR was determined using a representative 
sample from the Third National Health and Nutrition Examination Survey (NAHNES III, 
1988-1992) and from the 1999-2002 NAHNES with and without diabetes. Insulin 
resistance was defined using the homeostatic model assessment of IR (HOMA-IR). 
Subjects in the upper quartile of HOMA-IR were characterized as being insulin resistant.  
Following adjustment for covariates, the prevalence of IR in subjects from NHANES III 
without diabetes or IFG was 26.2% (95% CI 23.6–28.9). Prevalence of IR was 
significantly higher in subjects from the 1999-2002 NHANES; 32.2% (95% CI 29.5–
35.0) indicating a significant positive trend in IR among subjects with normoglycemia. In 
another cross-sectional analysis conducted by Li et al.(7), investigators sought to 
determine specific trends in hyperinsulinemia among U.S. adults without diabetes 
utilizing data from NHANES III and the 1999-2002 NHANES. Hyperinsulinemia was 
defined as residing in the upper 75th percentile of log-transformed fasting insulin. Across 
the entire sample, the mean fasting insulin level was significantly higher (p=0.025) in 
subjects from the 1999-2002 NHANES (2.16 ± 0.01) compared to those from NHANES 
III (2.12 ± 0.01). Moreover, the age-adjusted prevalence of hyperinsulinemia increased 
by 35.1% (25.8% in NHANES III to 34.8% in the 1999-2002 NHANES, p<0.001). 
 Bonora et al.(8) investigated the prevalence of IR among individual metabolic 
disorders in a sample of 888 subjects from the Bruneck study. Insulin resistance was 
defined as the lower limit of the top quintile of HOMA-IR distribution. A significant 
positive trend was seen across quintiles of IR and prevalence of IGT (p=0.011), 
hypercholesterolemia (p<0.001), hypertriglyceridemia (p<0.001), low high-density 
lipoprotein cholesterol (HDL-C, p=0.049), and hypertension (p=0.002). The prevalence 
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of IR was 65.9% in IGT subjects, 53.5% in subjects with hypercholesterolemia, 84.2% in 
subjects with hypertriglyceridemia, 88.1% in subjects with low HDL cholesterol, and 
58.0% in hypertensive subjects. Insulin resistance is a complex, multifactorial metabolic 
condition that is increasing in prevalence, even in euglycemic subjects. Furthermore, IR 
appears to be highly prevalent among several cardio-metabolic risk factors.   
Homeostatic model assessment of insulin resistance 
History and physiological rationale 
 In 1985, Matthews et al.(9) created a model known as the HOMA-IR to estimate 
both IR and β-cell function. The physiological basis for HOMA-IR utilizes the 
relationship between basal concentrations of glucose and insulin, reflecting the action of 
the negative feedback-loop between the liver and the β-cells(10). Hepatic IR can be 
estimated based on the effects of reduced insulin secretion capacity, leading to increased 
hepatic glucose efflux. This increase in basal plasma glucose stimulates increased 
secretion of insulin within the portal vein, until glucose levels return to normal: thus the 
“feed-back” loop between the liver and β-cells. The basal plasma insulin levels necessary 
to maintain normal glucose levels are directly proportional to the grade of IR(10). Based 
on these interactions between the liver and β-cells, a nonlinear computer model was 
created to allow for assessment of IR and β-cell function(9). This model allows for a 
prediction of either IR or β-cell function based solely on a subjects fasting insulin and 
basal glucose levels. The following represents the HOMA-IR equation: [fasting serum 
insulin (mU/ml) x fasting plasma glucose (mmol/l)]/22.5. It is important to note that 
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while HOMA-IR is primarily a reflection of hepatic IR, there is a 70% correlation 
between hepatic IR and peripheral IR.(2)   
Comparison to other techniques 
 Values from HOMA-IR have been compared and validated against several other 
techniques for assessing IR,(9,11) such as the euglycemic-hyperinsulnemic clamp, the 
hyperglycemic clamp, and the continuous infusion of glucose with model assessment 
(CIGMA). In the original study conducted by Matthews et al.(9), HOMA-IR was 
validated (via the Spearman correlation coefficient test) against several other methods for 
assessing IR, both in euglycemic and subjects with diabetes. Strong correlations were 
seen between HOMA-IR and the euglycemic hyperinsulinemic clamp in subjects with 
(Rs=0.92,p<0.0001) and without diabetes (Rs=0.83,p<0.01), the hyperglycemic clamp in 
a combined sample of subjects with and without diabetes (Rs=0.69,p=0.0005), and the 
CIGMA method in subjects with (Rs=0.97, p<0.0001) and without (Rs=0.69,p<0.02) 
diabetes. Bonora et al.(12) compared insulin sensitivity, assessed by a four hour 
euglycemic and hyperinsulinemic clamp, to HOMA-IR in 115 subjects with varying level 
of insulin sensitivity and glucose tolerance. Sixty-two subjects had diagnosed diabetes 
and 53 subjects were without diabetes. Results showed strong correlations between 
clamp-measured total glucose disposal and HOMA-IR (r=0.820, p<0.0001). Furthermore, 
strong correlations were seen between clamp measurements and HOMA-IR in men 
(r=0.800), women (r=0.796), younger (aged 50 years, r=0.832) and older (r=0.800) 
subjects, non-obese (BMI<27 kg/m2, r=0.800) and obese (r=0.765) subjects, subjects with 
(r=0.754) and without (r=0.695) diabetes, and normotensive (r=0.786) and hypertensive 
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(r=0.762) subjects. In 87 subjects with NGT, García-Estévez et al.(13) revealed a 
significant correlation (r=0.70, p=0.001) between HOMA-IR and CIGMA.  
HOMA-IR Uses (Cross-sectional and Prospective) 
 HOMA-IR has been utilized as a measure of IR in over 500 published 
articles(11). Furthermore, greater than 50% of those articles have utilized the model in 
subjects without diabetes(11). Many cross-sectional studies have utilized HOMA-IR as a 
measurement of IR(14-16). Ausk et al.(14) revealed a significant relationship between 
all-cause and CVD mortality across quartiles of HOMA-IR in subjects without diabetes. 
Healy et al.(15) investigated the associations between increasing levels of sedentary time 
and cardio-metabolic risk in a sample of 4,757 adults (≥20 years) from the 2003-2006 
NHANES. Results revealed a significant positive trend across quartiles of total sedentary 
time and HOMA-IR (p<0.001). Haffner et al.(16) investigated the correlations between 
HOMA-IR and fasting insulin in a cross-sectional analysis of 2,465 subjects from the San 
Antonio Heart Study. Results revealed a significant correlation between HOMA-IR and 
fasting insulin in subjects with (r=0.908) and without (r= 0.991) diabetes.  Utilizing data 
from the NHANES III, Durward et al.(17) investigated the risk of mortality across 
varying definitions of metabolic health. Metabolically healthy was defined as either: 1) 
HOMA-IR <2.5; 2) ≤2 Adult Treatment Panel (ATP) III metabolic syndrome criteria; 3) 
combined definition using ≤1 of the following: HOMA-IR ≥1.95 (or diabetes 
medications), triglycerides ≥1.7 mmol/L, HDL-C <1.04 mmol/L (males) or <1.30 
mmol/L (females), LDL-C ≥2.6 mmol/L, and total cholesterol ≥5.2 mmol/L (or 
cholesterol-lowering medications). Subjects considered metabolically unhealthy based on 
the HOMA-IR definition had a significantly greater hazard ratio for all-cause mortality 
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(2.07, p<0.01) compared to those who were considered metabolically healthy by HOMA-
IR definition.           
 HOMA-IR has also been used as a measure of IR in many prospective studies(18-
20). Bonora et al.(18) investigated the incidence rates and risk factors for type 2 diabetes 
in cohort of white individuals who participated in the Bruneck Study. Results revealed 
that subjects in the highest quartile of HOMA-IR had significantly higher odds of 
developing type 2 diabetes (OR 8.5, p<0.001). Furthermore, it was revealed that every 
one-standard deviation increase in HOMA-IR coincided with increased odds for 
developing type 2 diabetes (OR 1.7, p< 0.018). Another study conducted by Bonora et 
al.(20) revealed that a one-unit increase in HOMA-IR was associated with an increased 
odds for incident CVD during (OR 1.56, p<0.001) in subjects with type 2 diabetes. Sung 
et al.(19) investigated the relationship between HOMA-IR and incident hypertension in a 
sample of euglycemic, normotensive Korean adults (n= 10,894). Results revealed a 
significant trend across quartiles of HOMA-IR and incident hypertension after five years 
of follow-up (p<0.01). Furthermore, subjects in the third (OR 1.5, p<0.05) and fourth 
(OR 1.7, p<0.05) quartiles of HOMA-IR had significantly higher odds of developing 
hypertension compared to those in the first quartile.   
Misuses of HOMA-IR 
 The use of HOMA-IR as a measure of IR is not appropriate for all assessments 
and study designs. The use of HOMA-IR in animal studies has not been validated and 
also violates some physiological assumptions made by the model(11). HOMA-IR also 
cannot be used to report β-cell function in isolation(11). Due to the relationship between 
β-cell secretion rate and insulin sensitivity it is possible to misinterpret the results of the 
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model as issues with β-cell function when in actuality it is attributable to high insulin 
sensitivity and not failing β-cells(11). An example of this is using HOMA-IR as a 
measure of IR in a fit athlete with 50% β-cell function and 200% insulin sensitivity. A 
subject with 50% β-cell function would intuitively be considered to have failing β-cells. 
However, the attenuated β-cell function is attributable to high levels of insulin sensitivity 
and not complications with β-cells(11). Thus, this means using HOMA-IR in one subject, 
specifically in a highly insulin sensitive subject, would elicit a possible misinterpretation 
of the function of their β-cells.  
Muscular strengthening activities 
 Muscular strengthening activities (MSA) are exercise modalities that have been 
shown to help play a role in the prevention and management of multiple chronic diseases 
and metabolic risk factors. Currently the Department of Health and Human Services 
(DHHS) recommends participation in MSA at moderate or high intensity; involving all 
major muscle groups (the legs, hips, back, chest, abdomen, shoulders, and arms) ≥2 
days/week(21). The DHHS defines MSA as participation in activities that overload the 
muscles. These include: resistance training (RT), such as weight training, working with 
resistance bands, doing calisthenics utilizing body weight for resistance (such as push-
ups, pull-ups, and sit-ups), carrying heavy loads, or heavy gardening (such as digging or 
hoeing)(21).            
 The current prevalence estimates of MSA participation ranges from 
approximately 6%-31.7%(22-25). Utilizing data from the 2009 Health Styles survey, 
Loustalot et al.(25) reported that 31.7% of respondents reported participation in MSA ≥2 
days/week. However, only 6.0% of respondents reported adequate MSA including all 
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seven major muscle groups. The Centers for Disease Control (CDC) examined the 
prevalence of meeting the DHHS MSA recommendations using data from the 1998-2004 
National Health Interview Survey (NHIS)(24). Results revealed a prevalence of 19.4% 
(95% CI 19.0-20.3) in 2004. Using data from the 1998-2008 NHIS, Carlson et al.(22) 
reported a 21.9% (95% CI 21.2-22.7) prevalence of adequate MSA participation in 2008. 
The most recent estimates for MSA participation were reported by the CDC using data 
from the 2011 Behavior Risk Factor Surveillance Survey (BRFSS)(23). Analysis 
revealed a prevalence estimate of 29.3%. Based on these data it is estimated that the 
prevalence of meeting the DHHS MSA recommendations is approximately 20-30%. 
Relationship to insulin resistance/glycemic control 
 Several studies have revealed significant inverse associations between IR and 
MSA in subjects that are euglycemic(26-31).  Ahmadizad et al.(26) investigated the 
effect of resistance or endurance training on IR in 24 healthy males (35–48 years). Study 
subjects had no medical condition that would inhibit exercise participation. Furthermore, 
subjects had not participated in regular exercise for at least 12 months. Subjects were 
randomly assigned to one of three groups: endurance training group (n=8), RT group 
(n=8) or control group (n=8). Insulin resistance was assessed via HOMA-IR. Following 
intervention, significant reductions in IR were seen in both the resistance (38.5%, p<0.05) 
and endurance training groups (35.7%, p<0.05). No significant differences were seen 
between exercise intervention groups.        
 In a cross-sectional analysis conducted by Cheng et al.(27), investigators 
examined the associations between MSA and insulin sensitivity (measured via the 
qualitative insulin sensitivity check index [QUICKI](32)), fasting insulin, and fasting 
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glucose. Subjects (n=4,504) participated in the 1999-2004 NHANES and did not have 
diabetes. Muscular strengthening activity was divided into three categories: low (<1 
day/week), moderate (1–2.9), or high (≥3). Following adjustment for covariates, women 
reporting moderate (p=0.025) or high (p=0.021) amounts of MSA had significantly 
higher QUICKI levels compared to those reporting low levels of MSA. Furthermore, 
women reporting high levels of MSA had significantly lowered fasting insulin levels (p= 
0.007) compared to those reporting low amounts of MSA. In men, only those reporting 
high levels of MSA had significantly higher QUICKI levels (p=0.003) and significantly 
lowered fasting insulin levels (p=0.007) compared to those reporting low MSA levels.
 Miller et al.(28) investigated the effects of a 10-week isotonic RT program on 
glucose tolerance, fasting insulin and the insulin response to an OGTT. College-aged 
subjects without diabetes were used. Following intervention, significant changes were 
seen in basal plasma insulin levels (37.5%, p<0.05), indicating significant decreases in 
IR. Moreover, the insulin response to a 100-g OGTT was significantly reduced (18.0% 
p<0.05), further illustrating significant reductions in IR. In another trial, Miller et al.(29) 
investigated the effects of a 16-week RT intervention on IR in 11 healthy men (50-63 
years). Insulin resistance and action was assessed via a two-step hyperinsulinemic-
euglycemic glucose clamp and an OGTT. Following the RT intervention, there were 
significant decreases in both fasting plasma insulin levels (p<0.05) and insulin levels in 
response to an OGTT (p<0.05). Glucose infusion rates during the hyperinsulinemic-
euglycemic glucose clamp increased 24% (p<0.05) during low insulin infusion and 
increased 22% (p<0.05) during high insulin infusion; indicating increases in peripheral 
insulin sensitivity.           
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 Craig et al.(30) investigated the insulin response to an OGTT following a 12-
week RT intervention in six younger (23 ± 1 year) and nine older (63 ± 1 year) subjects. 
Insulin response to an OGTT was significantly reduced in both groups (p<0.05). The sum 
insulin response to an OGTT decreased by 31.8% in the younger group and decreased by 
32.6% in the elderly group, indicating reductions in peripheral IR. Kodama et al.(31) 
investigated the effects of low-intensity and low-volume exercise training on IR in 
elderly subjects. Subjects (n=56, 64±6 years), participated in a 12-week exercise 
intervention that included aerobic and RT. Results revealed a significant reduction in IR 
(21%, p<0.05), independent of BMI changes.       
 In a cross-sectional analysis conducted by Churilla et al.(33), investigators sought 
to determine the associations between meeting the current DHHS MSA recommendations 
and components of metabolic syndrome. Subjects (n=5,618, ≥20 years) participated in the 
1999-2004 NHANES. Metabolic syndrome was defined using the American Heart 
Association/ National Heart, Lung, and Blood Institute cut-points. Following adjustment 
for potential confounding, subjects reporting meeting the DHHS MSA recommendations 
had lower odds of having IFG (OR 0.71, p<0.05) compared to subjects reporting no 
MSA. Furthermore, the prevalence of IFG was significantly lower in subjects meeting the 
DHHS MSA recommendations (28.3%, 95% CI 24.8-32.1) compared to those reporting 
no MSA (38.0%, 95% CI 35.2-40.9).  
Relationship to lean body mass and insulin resistance 
 Intuitively, routine participation in sufficient amounts of MSA will lead to 
increases in lean body mass (LBM). Several studies have shown inverse associations 
between LBM and IR(28,34). Miller et al.(28) investigated the effects of a 10-week 
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isotonic RT on insulin response to and OGTT and basal insulin levels in college aged 
men without diabetes.  A significant increase in LBM (3.5%, p<0.05) was seen following 
intervention. Furthermore, the increase in LBM was highly correlated with the reductions 
in insulin in response to an OGTT (r = -0.89, p<0.05). In a study using NHANES III, 
Srikanthan et al.(34) investigated the associations between skeletal muscle index (SMI, a 
measure of LBM) and IR in subjects with and without diabetes.  Insulin resistance was 
investigated using HOMA-IR. Skeletal muscle index was categorized into quartiles. 
Following adjustment for covariates, results revealed a significant inverse dose-response 
relationship between quartiles of SMI and IR (p<0.0001). After exclusion of subjects 
with diabetes, the results remained significant (p<0.0001). Furthermore, results revealed 
that for every 10% increment increase in SMI, there was a 14% reduction in HOMA-IR 
in subjects without diabetes. 
Relationship between muscular strength and insulin resistance 
 Some studies have shown an inverse association between IR and muscular 
strength, a physiological adaptation to MSA(35,36). Barzilay et al.(35) investigated the 
associations between quadriceps muscle strength and IR. Subjects (n= 2,006, ≥70 years) 
were without diabetes and were considered to be well-functioning (self-reported no 
difficulty with walking one-quarter mile or walking up 10 steps without stopping). 
Insulin resistance was measured via HOMA-IR. A significant inverse association was 
seen between strength per kilogram of muscle mass and IR in white and black males and 
females (p<0.001). A significant inverse association was also seen between quadriceps 
muscle mass and IR (p<0.001).        
 Karelis et al.(36) examined the associations between a muscular strength index 
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(MSI, calculated by dividing the subject’s leg press 1-RM and LBM in kg) and insulin 
sensitivity in a cohort of obese and overweight postmenopausal women. Study subjects 
(n=82) were diabetes-free. Insulin resistance was assessed via the hyperinsulinemic-
euglycemic glucose clamp. The MSI was categorized into quartiles. Following covariate 
adjustment, a significant positive association was seen between MSI and insulin 
sensitivity (r=0.37, p<0.001). Furthermore, subjects in the highest quartile of MSI had 
higher levels of insulin sensitivity (p<0.05) compared to those in the first and second 
quartiles.  
Postulated mechanisms  
 There are several postulated mechanisms by which muscle contraction, and acute 
and chronic participation in exercise may play a role in the reduction of IR or the 
prevention of reaching an insulin resistive state(37-41). Several studies and reviews have 
discussed the effect of muscle contraction and exercise as a whole on IR. These 
mechanisms include: increased insulin sensitivity attributable to the effect of exercise on 
Glut4 expression and activation, the effect of exercise on glycogen synthase, effects on 
muscle fiber type, calcium levels, and increases in LBM.      
 Muscle contraction has been shown to lead to increases in tissue permeability and 
sensitivity to glucose(38). More specifically, several studies have revealed that both acute 
and chronic participation in exercise leads to an increase in insulin sensitivity via effects 
on Glut4 expression and activation(37,39,41-43). Glut4 plays a primary role in the uptake 
of glucose into tissue for use as fuel or for storage(37). The specific cellular mechanisms 
in which muscle contraction effects Glut4 activation and expression are not fully 
understood(37) but advances in microscopy techniques have given further insight into 
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these mechanisms(44). In a study conducted by Gjovaag et al.(39), investigators reported 
significant increases in Glut4 concentration (p<0.01) in the triceps brachii following a 
five to eight week strength protocol. Furthermore, Glut4 concentration was higher 
(p<0.01) in subjects participating in high loading (60% 1-RM) compared to lower loading 
(30% 1-RM); suggesting higher intensity training leads to increased exercise stimulated 
glucose uptake. Goodyear et al.(43) reported significant increases in the number of 
glucose transporters following electrically stimulated muscle contractions in the 
hindquarters of male rats.  Exercise has been shown to stimulate the increase in the 
activity of glycogen synthase, an enzyme that stimulates the synthesis of glycogen from 
glucose-6-phosphate, following exercise(42). This increase in enzyme concentration is 
attributable to increased permeability of muscle tissue and increased expression of 
Glut4(42).            
 Routine participation in RT has been shown to increase the number of type IIa 
(fast twitch red) fibers(45,46). In earlier research, Ivy et al.(38) revealed that insulin 
sensitivity is increased in both fast and slow twitch red fiber types. Similarly, Richter et 
al.(47) revealed the highest insulin sensitivity to be fast twitch red fibers and the lowest 
being fast twitch white fibers(47). This is due primarily to the high glycolytic and 
oxidative capacity of the fast twitch red fiber types(38). More recently, Mackrell et 
al.(48) revealed a two-fold increase in insulin-mediated glucose uptake in myosin heavy 
chain (MyHC) IIa fibers in rats compared to MyHC IIx fibers.  Gjovaag et al.(39) 
investigated the effects of RT on the conversion of MyHC IIx fibers to MyHC IIa. 
Results revealed significant increases in MyHC IIa fibers (p<0.05) as well as significant 
decreases in MyHC IIx fibers (p<0.05). Furthermore, a significant positive correlation 
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(r=0.73, p<0.01) was found between increases in MyHC IIa fibers and Glut4 
concentration.         
 Calcium may also contribute to the increases in insulin sensitivity due to 
exercise(37,38). Youn et al.(49) revealed calcium to stimulate glucose transport 
independent of muscle contraction. However, Goodyear et al.(37) noted that this 
activation of glucose transport is most likely not a direct effect of calcium but attributable 
to the activation of Protein Kinase C. Protein Kinase C is a calcium-dependent signaling 
kinase that could contribute to the regulation of contraction-stimulated glucose 
transport(37). Miller et al.(28) revealed a strong inverse association (r=-0.89, p<0.05) 
between insulin response to an OGTT and LBM in subjects without diabetes. This is 
indicative of a decrease in peripheral IR. One possible explanation is an increase in the 
clearance of insulin attributable to the increase in insulin sensitive tissues. Due to the rate 
of clearance for insulin being directly proportional to its binding capacity(50), an increase 
in availability of binding sites could potentially lead to increased sensitivity. The 
increases in LBM may also contribute to decreased IR due to increased area for glycogen 
storage(28).      
Summary  
 It is evident in the literature that IR is highly prevalent even in subjects without 
diabetes: approximately one-fourth to one-third depending upon the specific study(5-7). 
Furthermore, research has shown that the prevalence of IR in euglycemic subjects is 
following a positive trend(7). Insulin resistance is also highly prevalent among 
individuals with various metabolic health conditions(8). HOMA-IR has been shown to be 
a validated method of assessing IR in euglycemic subjects in both cross-sectional and 
27 
 
prospective subjects. It has also been shown to have a strong correlation with peripheral 
insulin sensitivity thus allowing for its use as a proxy measure for studies specifically 
investigating peripheral IR(2). Moreover, over 50% of studies utilizing the HOMA-IR 
method have investigated subjects without diabetes(11).      
 In the 11 studies identified in the literature investigating the association between 
MSA and IR, all have consistently shown an inverse relationship with participation in 
adequate volumes of MSA and IR levels in euglycemic subjects. Furthermore, studies 
have shown that physiological adaptations due to MSA participation (increases in LBM 
and increases in muscular strength) are inversely associated with IR. Many mechanisms 
have been proposed and investigated as to why these favorable associations are seen; 
however they are not fully understood. Nonetheless, it is evident that there is a significant 
inverse relationship between MSA and IR, even in euglycemic subjects.    
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Data Collection 
Data were obtained utilizing the National Health and Nutrition Examination 
Survey (NHANES). The NHANES is conducted by the National Center for Health 
Statistics (NCHS) and is a continuous survey that regularly releases public-use data 
files(1). Originally introduced in the 1960’s, the NHANES began as a series of surveys 
focusing on select populations and health outcomes. There are five series that have been 
conducted.  NHANES I began in 1971 and ended in 1974. NHANES II began in 1976 
and ended in 1980. NHANES III (phase 1) began in 1988 and continued through 1991. 
NHANES III (phase 2) began in 1991 and finished in 1994. In 1999, NHANES became a 
continuous survey, producing data sets in two-year cycles. The continuous NHANES 
changed its focus to a variety of health and nutrition measurements with respect to 
emerging disease and adverse health conditions. The NHANES is cross-sectional in 
nature and is characterized by a complex, multi-stage sampling design in order to obtain a 
representative sample of the U.S. population(2). The sampling technique is divided into 
four distinct stages to obtain a representative sample of the non-institutionalized U.S. 
population aged two months and older living in households(2). During stage 1 specific 
primary sampling units (PSUs) are selected.  These are mostly single counties or, in a few 
cases, groups of contiguous counties with probability proportional to a measure of size 
(PPS). Stage 2 is characterized by the division of the PSUs into segments (generally city 
blocks or their equivalent). Like the PSUs, these segments are divided with PPS. Stage 3 
is characterized by households within each segment being listed, and a sample is 
randomly drawn. In geographic areas where the proportion of groups selected for 
oversampling is high, the probability of selection for those groups is greater than in other 
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areas. In stage 4 individuals are chosen to participate in NHANES from a list of all 
persons residing in selected households. Individuals are drawn at random within 
designated age-sex-race/ethnicity screening subdomains(2).     
 A component of the NHANES is oversampling of specific demographics and 
characteristics of the population. The purpose for this technique is to ensure an adequate 
representation of certain minority groups (subjects) as well as increasing the reliability 
and precision estimates for these specific groups(2). Examples of oversampled subgroups 
in the 1999-2004 NHANES include: African Americans, Mexican Americans, families 
with low income, adolescents aged 12-19 years, and persons age ≥60 years.  
 The NHANES was designed to provide national estimates of the health and 
nutritional status of non-institutionalized U.S. civilians two months of age and older 
through both objective (examination) and subjective (interview) measures(1). The 
NHANES assesses demographic, socioeconomic, dietary and health-related aspects of 
life through interview. The examination takes place at a mobile examination center 
(MEC) where both physiological measurements and laboratory tests are administered by 
trained medical personnel(1).    
Subjects 
 The total 1999-2004 NHANES sample N was 31,126. Of those, 15,332 subjects 
were ≥20 years of age, the population of interest for this study. We excluded 833 women 
who reported being pregnant, and 8,781 subjects who were non-fasted. Subjects with 
diabetes (n=617) or pre-diabetes (n=833) were excluded from the study as well. 
Following exclusion of those with missing data (n=1,640) for any variable included in the 
analysis, 2,543 remained in our analysis as eligible study subjects. The final sample met 
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the following conditions: 1) adult men and women ≥20 years of age; 2) attended a 
morning MEC following an overnight fast; 3) if female, non-pregnant; 4) had complete 
data on all the variables of interest and 5) were without diabetes (glycosylated 
hemoglobin <5.7%, and answered no to the question DIQ010: (Other than during 
pregnancy, have you ever been told by a doctor or health care professional that you have 
diabetes or sugar diabetes?). 
Measures 
Dependent Variable: Muscular Strengthening Activity 
 Current recommendations set forth by the Department of Health and Human 
Services (DHHS) state that the healthy population should participate in MSA two or 
more days per week(3).  The dependent variable in this study was calculated from ‘self-
reported’ MSA patterns. The final sample provided responses to the following items, 
which came from the PA questionnaire file item PAD440: "Over the past 30 days, did 
you do any physical activities specifically designed to strengthen your muscles such as 
lifting weights, push-ups or sit-ups?) Include all such activities even if you have 
mentioned them before in the past 12 months." No self-reported MSA was used as the 
dependent variable in this study. 
Independent Variable: HOMA-IR       
 The primary independent variable was IR. We used the homeostatic model 
assessment of insulin resistance (HOMA-IR) as a measure for IR, calculated via the 
equation by Matthews et al.(4): [fasting serum insulin (mU/ml) x fasting plasma glucose 
(mmol/l) /22.5]. Age-adjusted quartiles of log-transformed HOMA-IR were created using 
39 
 
every 25th percentile based on weights specific to NHANES: Q1 (<0.20), Q2 (≥0.20 and 
<0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). HOMA-IR was log transformed due to the 
the data not being normally distributed following a test for normality.  
Other independent variables:         
 Other independent variables or potential mediating factors include age, gender, 
race/ethnicity, education, smoking, alcohol, waist circumference, and non-MSA specific 
leisure-time physical activity (LTPA). 
Age:            
 Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60. 
Gender:            
 Gender was dichotomized as male or female. 
Race/Ethnicity:          
 Four categories of race were created: non-Hispanic White, non-Hispanic Black, 
Mexican American and Other. 
Education:          
 Education was categorized into four groups: less than high school, high school 
graduate, some college, and college graduate. 
Smoking:          
 Three categories of smoking were created: current smoker, former smoker (quit 
within last six months), and non-smoker. 
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Alcohol:          
 Three categories of alcohol consumption were created based on the United States 
Department of Agriculture (USDA) and DHHS gender specific cut-points(5): non-drinker 
(0 drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above 
moderate (>1 [women], >2 [men] drinks/day). 
Waist circumference:           
 Waist circumference (WC) was used as a measure for adiposity and dichotomized 
by gender specific cut-points(6): men (elevated: ≥102cm, desirable <102cm), women 
(elevated: ≥88cm, desirable <88cm). 
Non-MSA specific Leisure-time physical activity      
 Leisure time physical activity was categorized into three levels based on the 2008 
DHHS PA guidelines(3): none (0 min/week), insufficient (1-149 min/week) and meeting 
the recommendations (≥150 min/week). The LTPA variable was created from a 
compendium of activities within the 1999-2004 NHANES. These activities are primarily 
aerobic activities. However, some activities, such as rock climbing or wrestling 
incorporate both anaerobic (resistance) and aerobic pathways. Within the NHANES, 
MSA is defined exclusively using the PAD440 question. The LTPA variable used in this 
study is mutually exclusive of the PAD440 question and has been used as a measure of 
aerobic PA in several studies(7,8).   
Data Analysis 
 The NHANES data are weighted to account for the complex survey design, 
oversampling, survey non-response, and post-stratification to match 2000 U.S. Census 
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population control totals. Subjects participating in the NHANES are assigned a weight 
that is equivalent to the reciprocal of their probability of selection. Due to the complex 
survey design, these base weights must be calculated utilizing the reciprocal of their final 
probability of selection. The final probability incorporates the following: the probability 
of the PSU being selected; the probability of a segment of the PSU being selected; 
probability of a household being selected; and the probability of an individual being 
selected. Base weights are also adjusted for non-response to the in-home interview when 
creating interview weights. They are further adjusted for non-response to the MEC exam 
when creating exam weights(9).        
 Compared to earlier NHANES cycles, the sample size in the two-year continuous 
cycle is smaller. Thus the use of a statistical software program, capable of handling the 
increased sampling variation is necessary. SAS-callable SUDAAN(12) was used to 
handle to complex survey design and create an unbiased estimate of the variance(10).  
Statistical Analysis 
 The data in this study were initially managed using SAS 9.2(11). SAS was used to 
conduct both complex variable recodes and validation of data coding. SAS-callable 
SUDAAN(12) was then used to conduct the analysis, incorporating sampling weights 
within the context of the correlated multi-stage complex sampling design inherent to 
NHANES. Age-adjusted prevalence estimates were calculated using PROC DESCRIPT. 
Non-overlapping 95% confidence intervals (CI) with coinciding p-values illustrate 
significance (p<0.05). Logistic regression (PROC RLOGIST) analysis was used to test 
the null hypotheses that individual regression coefficients are equal to zero for each 
quartile of HOMA-IR. The three logistic regression models created included the primary 
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independent variable HOMA-IR unadjusted; a second model adjusting for age, race, 
gender, education, smoking, alcohol consumption, WC and HOMA-IR; and a third model 
further adjusting for LTPA. 
Limitations 
 Aspects of the 1999-2004 NHANES may limit the findings of this study. A 
portion of this survey is based on self-reported data. These self-reported variables are 
subject to recall bias. Furthermore, the self-reported data is subject to social-desirability 
bias (a response provided to please the interviewer). The nature of the survey can be 
subject to interview bias. Due to the cross-sectional study design, causality cannot be 
established between variables. Measurement errors, coding errors, and sampling errors 
may also occur in survey designs. The final limitation is residual confounding, which is 
inherent to all survey research.   
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Activity in euglycemic U.S. Adults 
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Background: Muscular strengthening activity (MSA) has been shown to be inversely 
associated with insulin resistance (IR). We examined the associations between quartiles 
of the homeostatic model assessment of insulin resistance (HOMA-IR) and self-reported 
MSA in a nationally representative sample of euglycemic U.S. adults.  
Methods: Sample included adult participants (≥20 years of age [n=2,543]) from the 
1999-2004 National Health and Nutrition Examination Survey (NHANES). HOMA-IR 
was categorized into quartiles based on every 25th percentile. No self-reported MSA was 
the dependent variable.  
Results: Following adjustment for covariates, those with HOMA-IR values in third 
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of 
reporting no MSA. Following further adjustment for non-MSA specific leisure time 
physical activity, results remained significant (p<0.05 third, p<0.001 fourth). A 
significant positive trend was seen across quartiles of HOMA-IR (p=0.01) for odds of 
reporting no MSA.  
Conclusions: Having a higher HOMA-IR value is associated with greater odds of 
reporting no MSA in euglycemic U.S. adults.  
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The homeostatic model for insulin resistance (HOMA-IR) has been extensively 
used as a measure for insulin resistance (IR) in epidemiological studies. Greater levels of 
IR have been shown to be highly associated with incidence of type 2 diabetes(1,2) and 
cardiovascular disease (CVD)(3-6).  Interestingly, previous studies using surveillance 
data have also estimated that HOMA derived IR(7) and hyperinsulinemia(8) are highly 
prevalent in subjects who are apparently healthy.     
 Traditionally, muscular strengthening activity (MSA) has been examined as an 
independent predictor of IR in subjects without diabetes. Several studies have 
investigated these associations(9-16).  Miller et al.(9)  reported a significant reduction 
(37.5%, p<0.05) in basal insulin levels and insulin levels in response to an oral glucose 
tolerance test (OGTT) (p<0.05) in eight young healthy male subjects following a 10-
week high-resistance, isotonic weight-lifting program. Cheng et al.(13)  investigated the 
associations between volumes of MSA and IR, measured via the quantitative insulin 
sensitivity check index (QUICKI), in subjects without diabetes utilizing data from the 
1999-2004 National Health and Nutrition Examination Survey (NHANES). Results 
revealed significantly higher QUICKI levels in subjects reporting ≥1 day/week of MSA 
(p<0.05). Following adjustment for covariates, results remained significant in females but 
not males. Significance was only seen in volumes of MSA ≥3 days/week (p<0.05) in 
males.   
Currently, no studies have examined these associations using HOMA-IR as the 
independent variable. This novel approach, defined as using a disease or adverse 
metabolic condition as the independent variable and physical activity (PA) as the 
dependent varibale, has been used in few studies(17-21). Moreover, this approach allows 
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for a clinical interpretation of surevillance data, providing potential insight into PA 
patterns in diseased subjects.  The purpose of this study was to invesitgate the 
associations between quartiles of HOMA-IR and self-reported MSA in a representative 
sample of euglycemic adults in the United States (U.S.). To the extent of our knowledge, 
this is the first study to examine the assocations between quartiles of HOMA-IR and 
MSA in a representative sample of euglycemic U.S. adults.      
Methods 
 This study utilized six years of data from the 1999-2004 NHANES, a continuous 
survey conducted by the National Center for Health Statistics(22).  The NHANES was 
designed to provide national estimates of the health and nutritional status of non-
institutionalized U.S. civilians over the age of two months. The total 1999-2004 
NHANES sample N was 31,126, ages two months and above. Out of the 15,332 subjects 
(≥20 years of age) who participated in the 1999-2004 NHANES, we excluded 833 
women who reported being pregnant, and 8,781 subjects who were non-fasted. Subjects 
with diabetes (n=617) or pre-diabetes (n=833) were excluded from the study as well. 
Following exclusion of those with missing data (n=1,640) for any variable included in the 
analysis, 2,543 remained in our analysis as eligible study subjects.  The final sample met 
the following conditions: 1) adult men and women ≥20 years of age; 2) attended a 
morning medical exam in a mobile examination center following an overnight fast; 3) if 
female, non-pregnant; 4) had complete data on all the variables of interest and 5) were 
without diabetes (glycosylated hemoglobin <5.7%, and answered no to the question 
DIQ010: (Other than during pregnancy, have you ever been told by a doctor or health 
care professional that you have diabetes or sugar diabetes?). 
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Muscle Strengthening Activity  
Current recommendations set forth by the Department of Health and Human 
Services (DHHS) state that the healthy population should participate in MSA two or 
more days per week(23).  The dependent variable in this study was calculated from ‘self-
reported’ MSA. The final sample provided responses to the following items which came 
from the physical activity (PA) questionnaire file item PAD440: Over the past 30 days, 
did you do any physical activities specifically designed to strengthen your muscles such 
as lifting weights, push-ups or sit-ups? Include all such activities even if you have 
mentioned them before in the past 12 months. No self-reported MSA was used as the 
dependent variable in this study. 
Insulin Resistance 
The independent variable was IR. We used the HOMA-IR as a measure for IR; 
calculated via the equation by Matthews et al.(24): [fasting serum insulin (mU/ml) x 
fasting plasma glucose (mmol/l)]/22.5. Age-adjusted log-transformed quartiles of 
HOMA-IR were created using every 25th percentile based on weights specific to 
NHANES: Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and ≤0.55) and Q4 (>0.55).  
Covariates 
Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60. Four 
categories of race were created: non-Hispanic White, non-Hispanic Black, Mexican 
American and Other. Education was categorized into four groups: less than high school, 
high school graduate or GED, some college, and college graduate. Three categories of 
smoking were created: smoker, former smoker (quit within last six months), and non-
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smoker. Three categories of alcohol consumption were created based on the United States 
Department of Agriculture and DHHS gender specific cut-points: non-drinker (0 
drinks/day), moderate (>0 and ≤1 [women], >0 and ≤2 [men] drinks/day), and above 
moderate (>1 [women], >2 [men] drinks/day)(25). Waist circumference (WC) was used 
as a measure for adiposity and dichotomized by gender specific cut-points: men 
(elevated: ≥102cm, desirable <102cm), women (elevated: ≥88cm, desirable <88cm)(26). 
Leisure time physical activity (LTPA) was categorized into three levels: 0 min/week, >0 
to <150 min/week, and meeting the 2008 DHHS PA recommendations ≥150 
min/week(23). 
Statistical Analysis 
The data in this study were initially managed using SAS 9.2(27) which was used 
to conduct both complex variable recodes and data coding validation. SAS-callable 
SUDAAN(28) was then used to conduct the analysis, incorporating sampling weights 
within the context of the correlated multi-stage complex sampling design inherent to 
NHANES. Age-adjusted prevalence estimates were calculated using PROC DESCRIPT. 
Non-overlapping 95% confidence intervals (CI) with coinciding p-values illustrate 
significance (p<0.05). Logistic regression (PROC RLOGIST) analysis was used to test 
the null hypotheses that individual regression coefficients are equal to zero for each 
quartile of HOMA-IR. The three logistic regression models created included the primary 
independent variable HOMA-IR unadjusted, a second model adjusting for age, race, 
gender, education, smoking, alcohol consumption, WC and HOMA-IR, and a third model 
further adjusting for other non MSA specific LTPA.       
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Results 
 
 Following adjustment for covariates, those with HOMA-IR values in third 
(p<0.01) and fourth (p<0.001) quartiles were found to have significantly greater odds of 
reporting no MSA. Following further adjustment for non-MSA specific LTPA, results 
remained significant (p<0.05 third, p<0.001 fourth). A significant positive trend was seen 
across quartiles of HOMA-IR (p=0.01) for odds of reporting no MSA.  
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Table 1 provides a summary of the study sample characteristics.  
Table 1. Characteristics of study sample: 1999-2004 NHANES 
 
Covariates N Weighted % 
(SE) 
HOMA-IR   
Q1 731 31.60 (1.41) 
Q2 711 28.25 (0.97) 
Q3 618 23.48 (1.08) 
Q4 483 16.66 (0.99) 
Age   
20-29 512 22.18 (1.89) 
30-39 506 23.91 (1.37) 
40-49 505 20.18 (1.08) 
50-59 341 15.32 (0.94) 
≥60 679 16.31 (1.04) 
Gender   
Male 1281 48.87 (0.88) 
Female 1262 51.13 (0.88) 
Race   
Non-Hispanic White 1391 75.99 (2.05) 
Non-Hispanic Black 400 8.91 (1.18) 
Mexican American 596 6.85 (0.92) 
Other 156 8.25 (1.59) 
Education   
College graduate 520 25.37 (1.64) 
Some college 703 30.26 (1.14) 
High school/GED 580 25.93 (1.54) 
< High school 740 18.44 (0.91) 
Smoking   
Non-smoker 1309 49.95 (1.89) 
Former smoker 639 24.90 (1.35) 
Smoker 595 25.16 (1.51) 
Alcohol consumption   
Above Moderate 221 9.88 (1.05) 
Moderate 1610 65.73 (2.29) 
None 712 24.38 (2.31) 
WC   
Desirable 1446 59.77 (1.09) 
Elevated 1097 40.23 (1.09) 
LTPA   
Meets Recommendations 819 36.57 (2.08) 
Some 723 30.68 (1.69) 
None 1001 32.75 (1.57) 
 
Table 1. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated: 
≥88cm, normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets 
recommendations (≥150 minutes/week.) Q: Quartile; WC: Waist Circumference; MSA: Muscular 
strengthening activity; LTPA: Leisure-time physical activity. 
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 Table 2 provides prevalence estimates for reporting no self-reported MSA. The 
prevalence of reporting no MSA was significantly higher in subjects in the third (76.02%, 
95% confidence interval [CI] 71.06-80.36) and fourth (81.19%, 95% CI 76.56-85.09) 
quartiles of HOMA-IR compared to those in the first (63.64%, 95% CI 58.69-68.31). No 
significant differences were found for prevalence of no MSA in the second quartile of 
HOMA-IR compared to the first.        
 Table 3 illustrates the results of the logistic regression analysis of the associations 
between quartiles of HOMA-IR and no self-reported MSA in people without diabetes. 
The unadjusted odds of reporting no self-reported MSA were significantly greater in 
subjects in the third (Odds ratio [OR] 1.90, 95% CI 1.48-2.45) and fourth (OR 2.69, 95% 
CI 1.96-3.71) quartiles of HOMA-IR compared to those in the first. Following 
adjustment for age, gender, race, education, smoking status, alcohol consumption, and 
WC, results remained significant for the third (OR 1.59, 95% CI 1.13-2.23) and fourth 
(OR 2.00, 95% CI 1.37-2.91) quartiles. In the fully adjusted model, which included other 
non MSA specific LTPA, significance remained for the third (OR 1.51, 95% CI 1.07-
2.14) and fourth (OR 2.10, 95% CI 1.43-3.08) quartiles. 
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Table 2. Prevalence estimates for subjects reporting no MSA - 1999-2004 NHANES. 
Covariates Prevalence 95% CI p-for-trend 
HOMA-IR    
Q1 63.64 58.69-68.31 
p<0.001 
Q2 68.52 63.54-73.11 
Q3 76.02 71.06-80.36 
Q4 81.19 76.56-85.09 
Age    
20-29 56.84 51.76-61.78 
p<0.001 
30-39 66.55 60.60-72.01 
40-49 71.85 65.59-77.37 
50-59 73.28 67.77-78.16 
≥60 83.45 78.30-87.57 
Gender    
Male 67.77 63.99-71.33 
p<0.001 
Female 73.87 70.71-77.27 
Race    
Non-Hispanic White 69.27 65.70--72.62 
p<0.05 
Non-Hispanic Black 67.37 61.08-73.10 
Mexican American 80.75 77.26-83.82 
Other 80.71 74.41-85.75 
Education    
College graduate 56.90 51.81-61.85 
p<0.001 
Some college 68.54 64.65-72.18 
High school/GED 78.40 74.12-82.14 
< High school 84.47 80.09-88.03 
Smoking    
Non-smoker 67.37 63.63-70.90 
p<0.001 Former smoker 71.14 64.14-77.26 
Smoker 79.45 75.83-82.65 
Alcohol    
Above Moderate 67.34 60.57-73.45 
p<0.001 Moderate 67.49 64.36-70.47 
None 80.80 76.57-84.43 
WC    
Desirable 65.12 61.54-68.55 
p<0.001 
Elevated 79.45 76.29-82.28 
LTPA    
Meets 46.17 46.17-53.73 
p<0.001 Some 75.66 71.27-79.57 
None 90.08 87.63-92.09 
 
Table 2. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated: ≥88cm, 
normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets Recommendations (≥150 
minutes/week.) Q: Quartile; WC: Waist Circumference; MSA: Muscular strengthening activity; LTPA: 
Leisure-time physical activity. 
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Table 3.  Odds for reporting no MSA in those without diabetes - 1999-2004 NHANES. 
 
Variable Model 1
a 
Model 2
b 
Model 3
c 
HOMA-IR    
Q1 1.00 1.00 1.00 
Q2 1.27 (CI 0.96-1.68) 1.21 (CI 0.89-1.64) 1.25 (CI 0.88-1.77) 
Q3 1.90 (CI 1.48-2.45)** 1.59 (CI 1.13-2.23)** 1.51 (CI 1.07-2.14)* 
Q4 2.69 (CI 1.96-3.71)** 2.00 (CI 1.37-2.91)*** 2.10 (CI 1.43-3.08)*** 
Age    
20-29  1.00 1.00 
30-39  1.61 (CI 1.15-2.26)** 1.33 (CI 0.98-1.80) 
40-49  2.34 (CI 1.67-3.28)*** 2.23 (CI 1.59-3.13)*** 
50-59  2.22 (CI 1.67-3.28)*** 1.96 (CI 1.39-2.78)*** 
≥60  3.69 (CI 2.67-5.09)*** 3.10 (CI 2.26-4.24)*** 
Gender    
Male  1.00 1.00 
Female  1.43 (CI 1.14-1.80)** 1.51 (CI 1.06-1.63)* 
Race    
Non-Hispanic White  1.00 1.00 
Non-Hispanic Black  0.74 (CI 0.51-1.06)** 0.58 (CI 0.40-0.84)** 
Mexican American  1.36 (CI 0.94-1.98) 1.14 (CI 0.77-1.67) 
Other  1.58 (CI 0.94-2.65) 1.31 (CI 0.76-2.27) 
School    
College graduate  1.00 1.00 
Some college  1.53 (CI 1.16-2.03)** 1.32 (CI 0.97-1.80) 
High school or GED  2.41 (CI 1.84-3.16)*** 1.94 (CI 1.45-2.60)*** 
< High school  3.40 (CI 2.07-5.57)*** 2.28 (1.41-3.67)** 
Smoking    
Non-smoker  1.00 1.00 
Former smoker  1.19 (CI 0.89-1.60) 1.25 (CI 0.93-1.68) 
Smoker  1.94 (CI 1.46-2.58)*** 1.64 (CI 1.26-2.14)*** 
Alcohol    
Above moderate  1.00 1.00 
Moderate  1.19 (CI 0.83-1.59) 1.05 (CI 0.73-1.49) 
None  1.94 (CI 1.42-3.13)*** 1.90 (CI 1.28-2.82)** 
WC    
Desirable  1.00 1.00 
Elevated  1.55 (CI 1.30-1.84)*** 1.44 (CI 1.17-1.77)*** 
LTPA    
Meets Recommendations   1.00 
Insufficient   3.16 (CI 2.49-4.01)*** 
None   8.02 (CI 5.92-10.87)*** 
 
Table 3. Waist circumference: Men (elevated: ≥102cm, normal <102cm), Women (elevated: ≥88cm, 
normal <88cm). LTPA: None, Some (≥1 but <150 minutes/week.), Meets Recommendations (≥150 
minutes/week.) ***p<0.001, **p<0.01, *p<0.05 
aModel 1: unadjusted. bModel 2: adjusted for age, race, gender, education, smoking status, alcohol 
consumption, WC, and MSA. cModel 3: all covariates plus LTPA. WC: Waist Circumference; MSA: 
Muscular strengthening activity; Q: Quartile; LTPA: Leisure-time physical activity 
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Discussion 
The results of this analysis show a positive association between quartiles of 
HOMA-IR and the prevalence no self-reported MSA in euglycemic U.S. adults. This 
study adds to previous traditional work investigating the relationship between MSA and 
IR in healthy populations(9-16).  Miller et al.(9) investigated the effects of a 10-week 
resistance training (RT) program on basal insulin levels and insulin response to an 
OGTT. Results revealed significant reductions in basal insulin levels (p<0.05) and insulin 
levels in response to an OGTT (p<0.05) following the intervention. Another study 
conducted by Craig et al.(12) revealed significant decreases in insulin response (p<0.05) 
to an OGTT independent of age (31.8% younger, 32.6% elderly) in healthy subjects 
completing a 12-week RT program. The current study findings support previous 
prospective work, which indicates that MSA is inversely associated with IR.  
Two cross-sectional studies have also shown an association between IR and 
MSA(13,29). Churilla et al.(29) reported a significantly lowered odds (OR 0.71; 95% CI 
0.54-0.93) for having impaired fasting glucose (IFG), suggesting normal β-cell function 
in subjects reporting meeting the DHHS MSA recommendation compared to subjects 
reporting no MSA. In another analysis using NHANES 1999-2004, Cheng et al.(13) 
investigated the associations between MSA and insulin sensitivity (measured via 
QUICKI(30)) in euglycemic subjects. Results revealed a significant difference in 
QUCIKI levels for men and women reporting ≥1 day/week of MSA (p<0.05) compared 
to those reporting none. Following adjustment for age, race/ethnicity, physical activity 
other than MSA, BMI, smoking, alcohol consumption, and daily total caloric intake, 
results remained significant in females but not males. Significance was only seen in 
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volumes of MSA ≥3 days/week (p<0.05) in males. The results of these studies further 
indicate that MSA may be favorably associated with insulin sensitivity and glucose 
control.   
The aforementioned studies have all shown inverse associations between MSA 
and IR in subjects without diabetes. However, our study investigated the associations 
between increasing HOMA-IR quartiles and no self-reported MSA. This approach allows 
for the potential clinical examination and interpretation of surveillance data. Few studies 
have examined population based data using this method(17-21). Churilla et al.(21) 
reported the prevalence of meeting the 2008 DHHS PA recommendations to 59.1% 
among participants reporting high-cholesterol (HC) and 68.3% among participants not 
reporting HC (p<0.05), suggesting those with elevated cholesterol levels may not be as 
physically active as individuals with desirable levels. Another study by Churilla et al.(20) 
reported significantly lowered odds (OR 0.85, 95% CI 0.82-0.88) for meeting the DHHS 
PA recommendations in subjects with hypertension compared to those without 
hypertension, again suggesting lower physical activity levels among hypertensive 
individuals compared to those with desirable blood pressure values. Similar studies have 
investigated diabetes and PA patterns(17,18).  In a cross-sectional analysis using the 
behavioral risk factor surveillance system (BRFSS), Zhao et al.(18) revealed that subjects 
with diabetes reported lower levels of PA compared to those without diabetes. Also, 
subjects with diabetes were less likely to report meeting the 2008 DHHS PA 
recommendations compared to those without. These data suggest that subjects with 
diabetes, high cholesterol, CHD, and hypertension may be less likely to engage in a 
volume of PA that may prevent chronic diseases and promote health. Furthermore, the 
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use of this novel clinical approach in surveillance research may allow clinicians (e.g., 
physicians, physician assistants, nurse practitioners) to better utilize their time with 
patients who need lifestyle counseling and coaching. Our study suggests that subjects 
with higher levels of IR (specifically the upper 50th percentile) have greater odds of 
reporting no MSA.  Results from the few clinical analyses and the current analysis may 
begin to provide clinicians an understanding of behavioral patterns in population data, 
thus revealing an increased need for recommendations in therapeutic lifestyle 
interventions (PA, MSA, and dietary changes) within high risk or diseased populations.
 The current prevalence estimates for engaging in adequate amounts of MSA are 
approximately 21.9%-31.7%(31-34). Loustalot et al.(32) reported that 31.7% of 
respondents reported participation in MSA ≥2 days/week. The most recent estimate, 
using the 2011 BRFSS, is approximately 29.3%(34). From these data it can be estimated 
that approximately 70% of U.S. adults are not engaging in adequate amounts of MSA. 
Our study adds to these results specifically suggesting that eugluycemic subjects in the 
upper quartile (81.19%, 95% CI 76.56-85.09) and third quartile (76.02%, 95% CI 71.06-
80.36) of IR have a significantly higher prevalence of reporting no MSA compared to 
subjects in the lowest quartile (63.64%, 95% CI 58.69-68.31).    
 According to Barnes et al.(35) the prevalence of physicians recommending 
exercise or PA to adult patients is approximately 32.4%. Moreover, subjects with disease 
(e.g., diabetes, cardiovascular disease, cancer, hypertension) and subjects who were obese 
had a greater prevalence compared to those without disease or those with a desirable 
BMI. Despite this higher prevalence, Zhao et al.(18) showed that subjects with diabetes 
have lower odds of reporting participation adequate PA. Interestingly, subjects with IR, 
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who may have normal glucose levels, are in a state of increased risk for disease 
development and there is no data currently reporting the prevalence of physician 
recommended PA, specifically with IR status. Furthermore, our study results reveal the 
importance of continuing research into this area in order to combat the increasing 
incidence and prevalence of IR which has been shown to be highly associated with 
increased risk for CVD(3,4), diabetes(1,36) and a number of adverse metabolic 
conditions including obesity(37,38), dyslipidemia(39,40), inflammation(41) and 
hypertension(42).         
 A recent review(43) investigating the role of MSA and the risk of CVD revealed 
that MSA can improve insulin action, glucose response, reduce body fat and reduce 
visceral adipose tissue; all of which are risk factors for CVD at abnormal levels. A recent 
study by Grontved et al.(44), investigating the effects of MSA on type 2 diabetes, 
revealed that men who participate in aerobic training (AT) and MSA for at least 150 
minutes per week have a 59% reduction in risk for diabetes.  Furthermore, a study 
investigating MSA and risk for CHD by Tanasescu et al.(45) reported a 23% (RR 0.77, 
p<0.05) reduction in risk for CHD in men who participated in at least 30 minutes of MSA 
per week compared with men who did no MSA.  These results suggest that participation 
in routine PA, inclusive of MSA, could have a favorable impact on the risk for diabetes 
(which has been shown to be a possible vascular equivalent to CVD) as well as CVD. 
Due to the relationship between CVD and diabetes, as shown in a review by Grundy et 
al.(46), it is imperative for health care professionals to suggest PA, inclusive of MSA, to 
everyone capable of safely participating. Furthermore, due to the preventive effect MSA 
has on diabetes and CVD risk, it is vital that adults in higher risk categories (i.e., higher 
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levels of IR despite normal glucose levels), be counseled on therapeutic lifestyle changes, 
including engaging in MSA.    
The strengths of our study include strong external validity owing to the use of a 
large representative sample and the use of validated assays to measure insulin, glucose 
and glycosylated hemoglobin. Moreover, the novel approach to this study design, 
characterized by utilizing IR as a predictor variable rather than an outcome, provides 
insight into this relationship utilizing IR as the independent variable and health behavior 
(MSA) as the dependent variable.  The limitations of our study include the cross-sectional 
study design, which does not allow for causation to be established, residual confounding, 
and the use of questionnaires for the assessment of MSA, which may be subject to recall 
bias. 
Conclusions           
 Euglycemic adults that fall in the upper 50th percentile of HOMA-IR were more 
likely to report no MSA independent of several covariates. Muscular strengthening 
activity has been shown to improve insulin action, glycemic control, and reduce the risk 
for CVD and type 2 diabetes. Thus, it may become increasingly important for health care 
professionals to advocate MSA participation in all populations that can safely participate, 
specifically those with higher levels of IR.                                                                                                             
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Background: Waist circumference (WC) and body mass index (BMI) have been shown 
to be positively associated with insulin resistance (IR). The objective of this study was to 
examine the associations between quartiles of the IR (using the homeostatic model 
assessment of insulin resistance [HOMA-IR]) and BMI and WC in a nationally 
representative sample of euglycemic U.S. adults.      
Methods: Sample included adult participants (≥20 years of age) (N=2,442 [BMI model], 
N=2,438 [WC model]) from the 1999-2004 National Health and Nutrition Examination 
Survey (NHANES). HOMA-IR was categorized into quartiles. BMI and WC were 
examined continuously as the dependent variables.  
Results: Following adjustment for covariates, those with HOMA-IR values in the 
second, third and fourth quartiles had significantly higher BMI’s (p<0.001) compared to 
subjects in the first quartile. In the model using WC, significantly higher WC’s were 
found in subjects in the second, third, and fourth quartiles of HOMA-IR (p<0.001) 
compared to those in the first quartile. A significant linear trend was seen analyzing 
HOMA-IR linearly (p<0.001) in both models.  
Conclusions: Having a higher HOMA-IR value is associated with higher BMI and WC 
values in euglycemic subjects.   
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 Insulin resistance (IR) is characterized by the inability of the body to properly 
utilize endogenous insulin in an effective manner to maintain glucose homeostasis. The 
homeostatic model assessment of IR (HOMA-IR) has been utilized as a measure for IR in 
several epidemiological studies. Many studies have shown a significant association 
between higher levels of IR and cardiovascular disease (CVD)(1-3); all-cause 
mortality(4) as well as several cardio metabolic risk factors such as: inflammation(5,6) 
high blood pressure(7,8) and dyslipidemia(7,9) in subjects without diabetes. Furthermore, 
IR has been shown to be inversely associated with healthy lifestyle behaviors such as 
physical activity (PA)(10,11). Balkau et al.(11) revealed a significant inverse association 
between IR and PA independent of BMI and WC.      
 Insulin resistance is associated with adiposity, characterized by both body mass 
index (BMI) (9,12-14) and waist circumference (WC)(14-17). In a study conducted by 
Racette et al.(17), results revealed WC to be a stronger predictor of insulin sensitivity 
compared to fitness. Riserus et al.(13) showed BMI to be a stronger predictor of insulin 
sensitivity compared to PA, high-density lipoprotein cholesterol (HDL-C), saturated fat, 
fasting glucose, triglycerides, diastolic blood pressure (DBP) and socioeconomic status. 
Results from Nilsson et al.(16) revealed an elevated WC in women (>88 cm) to have a 
similar predictive value for IR as the National Cholesterol Education Program (NCEP) 
metabolic syndrome (MetS) definition.      
 While the relationship of adiposity and IR has been studied extensively, these 
studies have utilized adiposity as an explanatory variable rather than the dependent 
variable. This study investigated the associations between increasing levels of IR and 
adiposity (BMI and WC) in nationally representative sample of euglycemic United States 
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(U.S.) adults. To the extent of the author’s knowledge, this is the first study to investigate 
these associations using a nationally representative sample from the National Health and 
Nutrition Examination Survey (NHANES).  
Methods 
 This study utilized six years of data from the 1999-2004 NHANES, a continuous 
survey conducted by the National Center for Health Statistics(18). The NHANES was 
designed to provide national estimates of the health and nutritional status of non-
institutionalized U.S. civilians over the age of two months. The final samples for this 
study (N=2,475 [BMI model], N=2,475 [WC model]) met the following conditions: 1) 
adult men and women ≥20 years of age; 2) attended a morning medical exam in a mobile 
examination center following an eight to nine hour overnight fast; 3) if female, non-
pregnant; 4) had complete data on all the variables of interest and 5) were without 
diabetes (glycosylated hemoglobin <5.7%, and answered no to the question “Other than 
during pregnancy, have you ever been told by a doctor or health professional that you 
have diabetes or sugar diabetes?”). 
Insulin Resistance 
 The independent variable was IR. We used the HOMA-IR as a measure for IR; 
calculated via the equation by Matthews et al.(19): [fasting serum insulin (mU/ml) x 
fasting plasma glucose (mmol/l)]/22.5. Age-adjusted quartiles of log-transformed 
HOMA-IR were created using every 25th percentile based on weights specific to 
NHANES: Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55).  
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Adiposity 
 The dependent variables in the study were adiposity characterized by WC (cm) 
and BMI (kg/m2). Body mass index and WC were taken from the BMX Body Measures 
file (20) in NHANES and examined continuously. Adiposity measurements were 
collected using methods from the Anthropometric Standardization Reference Manual 
(21). 
Covariates 
 Five categories of age were created: 20-29, 30-39, 40-49, 50-59 and ≥60. Gender 
was categorized as either male or female. Four categories of race were created: non-
Hispanic White, non-Hispanic Black, Mexican American, and Other. Education was 
categorized into four groups: less than high school, high school graduate or GED, some 
college, and college graduate. Three categories of smoking were created: never smoked, 
former smoker (quit within the last six-months), and current smoker. C-reactive protein 
(CRP) was dichotomized: elevated (>3 and ≤10 mg/L) or normal (≤3 mg/L) (22). 
Hypertension was defined as having a systolic blood pressure (SBP) ≥135mmHg or a 
DBP  ≥85mmHg or currently undergoing pharmacological treatment for hypertension 
(23). Triglycerides were dichotomized as either elevated (≥150 mg/dl) or normal (<150 
mg/dl)(23). Physical activity was categorized into three levels: none (0 min/week), 
insufficient PA (1-150 min/week), and meeting the 2008 Department of Health and 
Human Services (DHHS) PA recommendations (≥150 min/week) (24). 
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Statistical Analysis 
 The data in this study were initially managed using SAS 9.2 (25). SAS was used 
to conduct both complex variable recodes and data coding validation. SAS-callable 
SUDAAN (26) was then used to conduct the analysis, incorporating sampling weights 
within the context of the correlated multi-stage complex sampling design inherent to 
NHANES. Non-overlapping 95% confidence intervals (CI) and corresponding p-values 
illustrate significance (p<0.05). Linear regression (PROC REGRESS) analysis was used 
to test the null hypotheses that individual regression coefficients are equal to zero for 
each quartile of HOMA-IR. Two regression models were created; one for WC and one 
for BMI. The model examining WC adjusted for age, race, gender, CRP, hypertension, 
triglycerides, PA and HOMA-IR. The model examining BMI adjusted for age, race, 
education, CRP, smoking, hypertension, triglycerides, PA and HOMA-IR. These two 
models differed in the specific covariates used in order to achieve a parsimonious model 
for each. 
Results 
 Subjects with HOMA-IR values in the second, third and fourth quartiles had 
significantly higher BMI’s (p<0.001) compared to subjects in the first quartile. In the 
model using WC, significantly higher WC’s were found in subjects in the second, third, 
and fourth quartiles of HOMA-IR (p<0.001) compared to those in the first quartile. A 
significant linear trend was seen analyzing HOMA-IR linearly (p<0.001) in both models. 
Table 1 summarizes the population characteristics.  
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Table 1. Population characteristics of study sample, National Health and Nutrition 
Examination Survey 1999-2004  
  Weighted % (SE) 
 N  
HOMA-IR   
Q1 2195 58.09 (1.52) 
Q2 774 18.35 (0.83) 
Q3 674 15.46 (0.80) 
Q4 533 11.10 (0.72) 
Age   
20-29 513 22.35 (1.88) 
30-39 517 24.71 (1.41) 
40-49 497 22.52 (1.17) 
50-59 319 14.94 (0.91) 
≥60 629 15.48 (1.03) 
Gender   
Male 1279 50.30 (0.94) 
Female 1196 49.70 (0.94) 
Race   
Non-Hispanic White 1329 75.01 (2.05) 
Non-Hispanic Black 394 9.02 (1.18) 
Mexican American 594 7.18 (0.92) 
Other 158 8.78 (1.67) 
Education   
College graduate 510 25.69 (1.68) 
 Some college 672 29.93 (1.10) 
High school graduate/GED 563 25.78 (1.56) 
< High school 730 18.60 (0.88) 
Smoking   
Never smoked 1298 50.88 (1.90) 
Former smoker 613 24.73 (1.42) 
Current smoker 564 24.39 (1.50) 
C-reactive protein   
Normal 1759 73.83 (1.36) 
Elevated 716 26.17 (1.36) 
Hypertension   
Normotensive 1536 67.25 (1.08) 
Hypertension 939 32.75 (1.08) 
Triglycerides   
Normal 1871 76.29 (1.27) 
Elevated 604 23.71 (1.27) 
Physical Activity   
Meets recommendations 976 33.15 (1.67) 
Insufficient 691 29.88 (1.70) 
None 808 36.97 (2.11) 
 
Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP ≥135mmHg 
or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated (>3 and ≤10 
mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl) PA: None, 
Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) HOMA-IR: homeostatic 
model assessment of insulin resistance. SE: Standard error. 
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 Table 2 illustrates the results of the linear regression analysis examining the 
associations between WC and independent variables among those without diabetes. 
Following adjustment for covariates, significantly greater WC levels (β=19.44, p<0.001) 
were observed in subjects in the greatest quartile of IR when compared to the other 
quartiles. Subjects in the third quartile of IR, had significantly greater WC levels 
(β=11.93, p<0.001) compared to the referent group and second quartile. Furthermore, 
subjects in the second quartile of IR had significantly higher WC values (β=6.63, 
p<0.001) compared to the referent group. When examining HOMA-IR linearly, a 
significant relationship was revealed with WC (β=3.75, p<0.001).  
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Table 2. β coefficients for regression analysis examining associations between HOMA-IR and waist 
circumference in centimeters 
 
Categorical Regression  Linear Regression 
 
Covariates 
 
Waist Circumference 
(95% CI) 
 
Covariates 
 
Waist Circumference 
(95% CI)  
 β  β 
HOMA-IR  HOMA-IR  
Q1 0.00 
HOMA-IR 3.75 (2.75-4.76)*** 
Q2 6.63 (5.51,7.76)*** 
Q3 11.93 (10.64,13.21)*** 
Q4 19.44 (17.73,21.14)*** 
Age  Age  
20-29 0.00 20-29 0.00 
30-39 2.32 (0.64,3.99)** 30-39 2.30 (0.74,3.86)** 
40-49 3.48 (1.85,5.10)*** 40-49 3.68 (1.99,5.36)*** 
50-59 5.61 (4.02,7.20)*** 50-59 5.99 (4.25,7.74)*** 
≥60 4.58 (2.64,6.51)*** ≥60 4.85 (2.92,6.79)*** 
Gender  Gender  
Male 0.00 Male 0.00 
Female -7.21 (-8.34,-6.07)*** Female -7.27 (-8.50,-6.04)*** 
Race  Race  
Non-Hispanic White 0.00 Non-Hispanic White 0.00 
Non-Hispanic Black -1.30 (-2.83,0.22) Non-Hispanic Black -1.62 (-3.29,0.06) 
Mexican American -2.43 (-4.02,-0.84)* Mexican American -2.05 (-3.75,-0.34)* 
Other -2.44 (-5.05,0.16) Other -2.27 (-4.84,0.29)* 
C-reactive protein   C-reactive protein   
Normal 0.00 Normal 0.00 
Elevated 5.78 (4.53,7.02)*** Elevated 5.90 (4.62,7.18)*** 
Hypertension  Hypertension  
Normotensive 0.00 Normotensive 0.00 
Hypertension 2.38 (1.10,3.67)*** Hypertension 2.51 (1.28,3.75)*** 
Triglycerides  Triglycerides  
Normal 0.00 Normal 0.00 
Elevated 0.68 (-0.67,2.02) Elevated 1.45 (0.23,2.67)* 
Physical Activity  Physical Activity  
Meets recommendations 0.00 Meets recommendations 0.00 
Insufficient 0.70 (-0.53,1.92) Insufficient 1.15 (-0.22,2.52) 
None 1.19 (0.41,1.97)** None 1.75 (0.71,2.80)*** 
 
Table 2. Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP 
≥135mmHg or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated 
(>3 and ≤10 mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl) PA: 
None, Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) ***p<0.001, 
**p<0.01, *p<0.05. Model: adjusted for age, race, gender, CRP, hypertension, triglycerides, PA, HOMA-
IR.  PA: Physical activity. CRP: C-reactive protein. HOMA-IR: homeostatic model assessment of insulin 
resistance, CI: Confidence interval. β: Beta. 
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 Table 3 illustrates the results of the linear regression analysis examining the 
associations between BMI and independent variables among those without diabetes. 
Significant differences in BMI were revealed in subjects in the second (β=2.58, p<0.001), 
third (β=4.37, p<0.001) and fourth (β=7.63, p<0.001) quartiles for IR compared to the 
referent group. Furthermore, significant differences in BMI levels were found between 
the second, third and fourth quartiles of HOMA-IR (p<0.001). Similar to WC, when 
examining HOMA-IR linearly, a significant relationship was revealed with BMI (β=1.46, 
p<0.001).  
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Table 3. β coefficients for regression analysis examining associations between HOMA-IR and body 
mass index in kg/m
2
 
 
Categorical Regression Linear Regression 
 
Covariates 
 
Body Mass Index 
(95% CI) 
 
Covariates 
 
Body Mass Index 
(95% CI) 
 β  β 
HOMA-IR  HOMA-IR  
Q1 0.00 
HOMA-IR 1.46 (1.08,1.84)*** 
Q2 2.58 (0.21,3.01)*** 
Q3 4.37 (3.86,4.88)*** 
Q4 7.63 (6.92,8.34)*** 
Age  Age  
20-29 0.00 20-29 0.00 
30-39 0.36 (-0.27,0.98) 30-39 0.39 (-0.22,1.01) 
40-49 0.33 (-0.40,1.06) 40-49 0.43 (-0.33,1.18) 
50-59 0.52 (-0.08,1.13) 50-59 0.68 (0.04,1.33)* 
≥60 -0.81 (-1.55,-0.06)* ≥60 -0.70 (-1.40,-0.00)* 
Race  Race  
Non-Hispanic White 0.00 Non-Hispanic White 0.00 
Non-Hispanic Black      0.94 (0.28,1.60)** Non-Hispanic Black      0.77 (0.11,1.44)* 
Mexican American -0.23 (-0.92,0.46) Mexican American -0.15 (-0.85,0.55) 
Other -0.17 (-1.24,0.91) Other -0.23 (-1.28,0.83) 
Education  Education  
College graduate 0.00 College graduate 0.00 
 Some college 0.21 (-0.34,0.75)  Some college 0.37 (-0.24,0.97) 
High school graduate/GED 0.37 (-0.12,0.87) High school graduate/GED 0.43 (-0.08,0.94) 
< High school 0.15 (-0.44,0.74) < High school 0.33 (-0.42,1.07) 
C-reactive protein   C-reactive protein   
Normal 0.00 Normal 0.00 
Elevated 2.28 (1.72,2.84)*** Elevated 2.32 (1.71,2.59)*** 
Smoking  Smoking  
Never smoked 0.00 Never smoked 0.00 
Former smoker 0.14 (-0.48,0.76) Former smoker 0.10 (-0.50,0.70) 
Current smoker -0.81 (-1.49,-0.13)* Current smoker -0.96 (-1.71,-0.21)* 
Hypertension  Hypertension  
Normotensive 0.00 Normotensive 0.00 
Hypertension 1.03 (0.55,1.51)*** Hypertension 1.07 (0.56,1.59)*** 
Triglycerides  Triglycerides  
Normal 0.00 Normal 0.00 
Elevated  -0.02 (-0.47,0.44) Elevated 0.26 (-0.18,0.70) 
Physical Activity  Physical Activity  
Meets recommendations 0.00 Meets recommendations 0.00 
Insufficient 0.03 (-0.43,0.50) Insufficient 0.19 (-0.37,0.76) 
None 0.04 (-0.34,0.42) None 0.24 (-0.27,0.74) 
 
Table 3. Q1 (<0.20), Q2 (≥0.20 and <0.37), Q3 (≥0.37 and <0.55) and Q4 (≥0.55). Hypertension: SBP 
≥135mmHg or a DBP ≥85mmHg. Normotensive: SBP <135mmHg and a DBP <85mmHg. CRP: elevated 
(>3 and ≤10 mg/L) or normal (≤3 mg/L). Triglycerides: elevated (≥150 mg/dl) or normal (<150 mg/dl). 
PA: None, Insufficient (≥1 but <150 min/wk.), Meets Recommendations (≥150 min/wk.) ***p<0.001, 
**p<0.01, *p<0.05. Model: adjusted for age, race, education, smoking, CRP, hypertension, triglycerides, 
PA, HOMA-IR.  PA: Physical activity. CRP: C-reactive protein. HOMA-IR: homeostatic model 
assessment of insulin resistance, CI: Confidence interval. β: Beta. 
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 Table 4 illustrates the mean WC and BMI level percentages across quartiles of 
HOMA-IR. Furthermore, a significant difference was found in mean levels of WC 
(second: third: 96.02, fourth: 102.92, p<0.01) and BMI (second: 26.35, third: 27.92, 
fourth: 30.97, p<0.001) in the third and fourth quartiles of HOMA-IR compared to those 
in the first quartile (WC: 91.14, BMI: 23.77). Moreover, significant differences were 
found between subjects in the fourth quartile compared to those in the third quartile of 
HOMA-IR (p<0.01) as well as between the second and third quartiles (p<0.01). Trend 
analysis revealed a significant positive trend between BMI and quartiles of HOMA-IR 
(p<0.001) as well as WC and quartiles of HOMA-IR (p<0.001). When examining the 
relationship between adiposity measurement and HOMA-IR linearly, both BMI 
(p<0.001) and WC (p<0.001) were found to have a significant positive linearly 
relationship with HOMA-IR. 
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Table 4. Means values of Waist Circumference (cm) and Body Mass Index (kg/m
2
) across quartiles of 
HOMA-IR 
 
 
HOMA-IR Quartile 
 
WC means (95% CI) 
 
BMI means (95% CI) 
Q1 84.59 (83.87,85.32) 23.77 (23.53,24.00) 
Q2 91.23 (90.55,91.90) 26.35 (26.00,26.69) 
Q3 96.52 (95.41,97.63) 28.14 (27.67,28.60) 
Q4 104.03 (102.40,105.66) 31.40 (30.73,32.07) 
p-for-trend 
(categorical  
HOMA-IR) 
p<0.001 p<0.001 
p-for-trend  
(linear HOMA-IR) 
p<0.001 p<0.001 
 
Q: Quartile; WC: Waist Circumference; BMI: Body Mass Index; kg/m2: Body weight in kilograms 
divided by height in meters squared; HOMA-IR: Homeostatic model assessment of insulin 
resistance; CI: Confidence interval; cm: Centimeters.  
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Discussion 
 The results of this study illustrate a positive dose-response relationship between 
HOMA-IR and two commonly utilized health indicators that have been shown to be 
highly correlated with adiposity in euglycemic U.S. adults. Significantly greater values 
for WC were seen in subjects falling in the second, third and fourth quartiles of HOMA-
IR compared to the first quartile. Similarly, significantly higher mean values for BMI 
were seen in the second, third and fourth quartiles of HOMA-IR compared to the first 
quartile. Our results add to existing cross-sectional studies investigating these 
associations in U.S. adults(12,15-17,27). In a study of 4,800 Japanese men, Tabata et 
al.(15) investigated the associations between increasing levels of WC and elevated 
HOMA-IR. Compared to those with a WC <80 cm, subjects with a WC 80-84 cm (OR 
3.2, 95% CI 2.3–4.3), 85-89 cm (8.2, 95% CI 6.1–11.0), 90-94 cm (15.2, 95% CI 11.1–
20.8), or ≥95 cm (45.2, 95% CI 31.8–64.4) were significantly more likely to have an 
elevated HOMA-IR level.        
 The findings of this study are also consistent with several prospective(13,28,29) 
and retrospective studies(30) as well as a randomized control trial(14). Wahrenberg et 
al.(30) revealed that a WC ≥100 cm had a higher predictor value for IR measured by 
HOMA-IR in males and females compared to a WC <100 cm. Furthermore, a higher 
prevalence of IR (defined as HOMA-IR score >3.99) was found in subjects with a WC 
≥100 cm (277 males; 388 females) compared to those <100 cm (7 males; 25 females). 
Another study conducted by Riserus et al.(13) found BMI to be a stronger predictor of 
insulin sensitivity compared to PA, HDL-C, saturated fat, fasting glucose, triglycerides, 
DBP and socioeconomic status. Following exclusion of overweight and obese subjects, 
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BMI remained the strongest predictor.       
 Increased levels of adiposity have been shown to be independently associated 
with increased risk for many adverse health conditions such as CVD(31-33), coronary 
heart disease(34), diabetes(33,35,36) as well as all-cause mortality(32). Furthermore, 
adiposity has been shown in several studies to be associated with several CVD risk 
factors such as hypertension(37,38), dyslipidemia(37,38), and MetS(37,39). Katzmarzyk 
et al.(40) revealed an augmented WC (≥102 cm) to be associated with increased risk for 
CVD, independent of having ≥2 MetS risk factors. Insulin resistance has also been shown 
to be independently associated with CVD(1-3), all-cause mortality(4), and diabetes(3) as 
well as several cardio metabolic risk factors such as: inflammation (5,6) high blood 
pressure(7,8) and dyslipidemia(7,9); in subjects without diabetes. These results illustrate 
the impact augmented levels of adiposity and IR can have on future CVD risk, even in 
euglycemic subjects.          
 The results of our study revealed strong associations between HOMA-IR and 
measurements of adiposity independent of PA. Several studies have shown inverse 
associations between IR and PA(10,11) as well as PA and adiposity(41-43). A cross-
sectional analysis conducted by Balkau et al.(11) investigated the associations between 
insulin sensitivity and PA in subjects without CVD and not treated with pharmacotherapy 
for diabetes, hypertension, dyslipidemia, or obesity. Results revealed significant 
associations between total activity and increased insulin sensitivity independent of BMI 
and adiposity. While our study focused on the associations between IR and adiposity, no 
significant mediating effects were seen, attributable to PA. Thus, our results speak to the 
strength of association between IR and adiposity independent of PA, specifically in 
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euglycemic subjects.           
 The strengths of our study include strong external validity owing to the use of a 
large representative sample, consistent validated measurements for WC and BMI, and the 
use of validated assays to measure insulin, glucose and glycosylated hemoglobin. 
Additionally, our results are consistent with others demonstrating a positive relationship 
between IR and adiposity. Finally, the novel approach to this study design, characterized 
by utilizing HOMA-IR as the explanatory variable and adiposity measures as the 
dependent variables provides further insight into this relationship.  The limitations of our 
study include the cross-sectional study design, which does not allow for causation to be 
established between variables, and the use of questionnaires for the assessment of PA, 
which is subject to recall bias. 
Conclusions          
 In conclusion, adults without diabetes that fall in the 25th percentile and above of 
HOMA-IR had greater WC values and those falling into the 25th percentile or higher of 
HOMA-IR possessed greater BMI values compared to subjects in the lower 25th 
percentile. Insulin resistance and increased adiposity have been shown to be 
independently associated with increased risk for CVD, CHD, and diabetes. Our study 
revealed that higher levels of IR are associated with increased WC and BMI, independent 
of PA among euglycemic adults. Our study suggests that future research into the 
deleterious relationships between IR and increased adiposity should consider the effects 
in those considered euglycemic as well as the possible mediating effects of increased 
volumes of PA.  
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